Stromal cell‐derived CSF‐1 blockade prolongs xenograft survival of CSF‐1‐negative neuroblastoma
Open Access
- 26 August 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 126 (6), 1339-1352
- https://doi.org/10.1002/ijc.24859
Abstract
The molecular mechanisms of tumor–host interactions that render neuroblastoma (NB) cells highly invasive are unclear. Cancer cells upregulate host stromal cell colony‐stimulating factor‐1 (CSF‐1) production to recruit tumor‐associated macrophages (TAMs) and accelerate tumor growth by affecting extracellular matrix remodeling and angiogenesis. By coculturing NB with stromal cells in vitro, we showed the importance of host CSF‐1 expression for macrophage recruitment to NB cells. To examine this interaction in NB in vivo, mice bearing human CSF‐1‐expressing SK‐N‐AS and CSF‐1‐negative SK‐N‐DZ NB xenografts were treated with intratumoral injections of small interfering RNAs directed against mouse CSF‐1. Significant suppression of both SK‐N‐AS and SK‐N‐DZ NB growth by these treatments was associated with decreased TAM infiltration, matrix metalloprotease (MMP)‐12 levels and angiogenesis compared to controls, while expression of tissue inhibitors of MMPs increased following mouse CSF‐1 blockade. Furthermore, Tie‐2‐positive and ‐negative TAMs recruited by host CSF‐1 were identified in NB tumor tissue by confocal microscopy and flow cytometry. However, host‐CSF‐1 blockade prolonged survival only in CSF‐1‐negative SK‐N‐DZ NB. These studies demonstrated that increased CSF‐1 production by host cells enhances TAM recruitment and NB growth and that the CSF‐1 phenotype of NB tumor cells adversely affects survival.Keywords
This publication has 52 references indexed in Scilit:
- Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndromeProceedings of the National Academy of Sciences, 2008
- Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivoInternational Journal of Cancer, 2008
- Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasisJournal of Clinical Investigation, 2007
- Colon Cancer Cell–Derived Tumor Necrosis Factor-α Mediates the Tumor Growth–Promoting Response in Macrophages by Up-regulating the Colony-Stimulating Factor-1 PathwayCancer Research, 2007
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisCell, 2006
- Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formationCancer Cell, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseasesEuropean Journal Of Cancer, 1996
- The effect of N-myc amplification and expression on invasiveness of neuroblastoma cellsJournal of Pediatric Surgery, 1993
- The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1Cell, 1985